| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $71K | -97.6% |
| Cost of Revenue | $218K | -95.5% |
| R&D Expense | $4.5M | -24.3% |
| SG&A Expense | $16.3M | -33.7% |
| Operating Income | -$21.8M | +51.0% |
| Pre-tax Income | -$2.5M | -108.7% |
| Income Tax | $0 | — |
| Net Income | $401K | -99.0% |
| EPS (Basic) | -$5.63 | -270.6% |
| EPS (Diluted) | -$5.63 | -1226.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | +29.8% |
| Accounts Receivable | $15K | -16.7% |
| Current Assets | $2.6M | +18.2% |
| Total Assets | $38.8M | +26.6% |
| Current Liabilities | $14.8M | -58.1% |
| Total Liabilities | $16.5M | -56.2% |
| Stockholders' Equity | $34.0M | +1461.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.2M | +84.5% |
| Capital Expenditures | $31K | -43.6% |
| Investing Cash Flow | -$31K | +99.8% |
| Financing Cash Flow | $5.6M | -82.1% |
| Free Cash Flow | -$5.2M | +84.4% |